Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | FPR2 | P25090 | 2/20 | 0.47 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 4/20 | 0.46 |
| ▸ | MMP9 | P14780 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.45 |
| ▸ | CPA3 | P15088 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7265100 | 0.86 | ALDH1A1 (0.56) | MMENPSR1FPR2NAALAD2MMP2 | |
| SCHEMBL7272751 | 0.86 | ALDH1A1 (0.56) | MMENPSR1FPR2NAALAD2MMP2 | |
| SCHEMBL20153838 | 0.85 | MMP1 (0.49) | MMP2MMP9 | |
| SCHEMBL27349758 | 0.85 | ATM (0.53) | L3MBTL1 | |
| SCHEMBL29358407 | 0.81 | KDM6B (0.51) | MMECYP1A2FOLH1 | |
| SCHEMBL25386615 | 0.80 | POLB (0.56) | MMENPSR1NAALAD2CYP1A2MMP2 | |
| SCHEMBL29631981 | 0.78 | KDM4E (0.42) | MMEFOLH1CPA3 | |
| SCHEMBL31549503 | 0.78 | TGFBR1 (0.37) | MME | |
| SCHEMBL29024583 | 0.76 | MME (0.38) | MME | |
| SCHEMBL7406797 | 0.75 | ALDH1A1 (0.54) | MMENPSR1NAALAD2CYP1A2MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116323634-A | Modification of protein oligomers forming nanopores | 牛津纳米孔科技公开有限公司 | 2023-06-23 | — | — | CN | disclosed |